NCT01471158

Patient Preference Comparison of AZARGA Versus COSOPT in Patients With Glaucoma

Patient Preference Comparison of AZARGA Versus COSOPT After Single Doses in Patients With Open-Angled Glaucoma or Ocular Hypertension

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 120 (actual)
• Sponsor: Alcon Research · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to assess patient preference of AZARGA® compared to COSOPT® after a single drop of each medication is administered to both eyes, in patients with open-angled glaucoma or ocular hypertension.

Conditions

• Glaucoma

Interventions

Type	Name	Description
DRUG	Brinzolamide/Timolol Maleate Fixed Combination (AZARGA)	Brinzolamide/timolol maleate fixed combination, one drop instilled in one eye at baseline, followed by one drop instilled in each eye once in either first intervention period or second intervention period.
DRUG	Dorzolamide/timolol Maleate Fixed Combination (COSOPT)	Dorzolamide/timolol maleate fixed combination, one drop instilled in one eye at baseline, followed by one drop instilled in each eye once in either first intervention period or second intervention period.

Timeline

• Start date: 2010-09-01
• Primary completion: 2011-05-01
• Completion: 2011-05-01
• First posted: 2011-11-15
• Last updated: 2016-11-21

Locations

1 site across 1 country: Argentina